steroids
1 product
9 abstracts
Abstract
First-line treatment of fecal microbiota transplantation for immune-mediated colitis.Org: University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center,
Abstract
Molecular predictors and mechanisms of immune checkpoint inhibitor-induced myocarditis: A case-control study with translational correlates.Org: Departments of Medicine and Oncology, McGill University, Centre de recherche du CHUM, Institut du Cancer de Montréal, Meakins-Christie Laboratories, Department of Medicine, McGill University Health Centre, Division of Cardiology, McGill University,
Abstract
Uptake of recommendations for broadening clinical trial eligibility criteria for patients with brain metastasis and leptomeningeal disease in lung cancer clinical trials: A systematic review.Org: Geisel School of Medicine at Dartmouth,
Abstract
Patient-reported treatment-related symptoms and use of the PRO-CTCAE for multiple myeloma clinical trials: A qualitative interview study.Org: Vector Psychometric Group, LLC, Janssen Global Services, LLC,
Abstract
Identifying molecular targets for rational immunosuppressive strategies in patients with immune checkpoint therapy-induced myocarditis and myositis.Org: The University of Texas MD Anderson Cancer Center, University of Texas Health Science Center, MD Anderson Cancer Center at Cooper, MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center,
Abstract
Impact of bridging therapy (BT) on outcome of relapsed refractory multiple myeloma (RRMM) with Ide-cel CAR T-cell therapy: Real-world experience from the US myeloma CAR T consortium.Org: Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, UT Southwestern Medical Center, Medical University of South Carolina Hollings Cancer Center, H. Lee Moffitt Cancer Center and Research Institute, Stanford University School of Medicine,
Abstract
Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM).Org: Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, MD Anderson Cancer Center, Houston, TX, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, Division of Hematologic Malignancies and Cellular Therapeutics (HMCT), University of Kansas Medical Center, Kansas City, KS, Virginia Commonwealth University Massey Cancer Center, Richmond, VA, Levine Cancer Institute, Charlotte, NC, Mayo Clinic Florida, Jacksonville, FL, Mayo Clinic, Phoenix, AZ, Dana-Farber Cancer Institute, Palm Beach, FL, Dana-Farber Cancer Institute, Boston, MA, H. Lee Moffitt Cancer Center, Tampa, FL, City of Hope Comprehensive Cancer Center, Duarte, CA, The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, Cleveland Clinic Taussig Cancer Center, Cleveland, OH, City of Hope Comprehensive Cancer Center, Durante, CA, Mayo Clinic, Rochester, MN, Stanford University School of Medicine, Stanford, CA,
Abstract
COVID-19 infection in patients on anti-CD20 monoclonal antibodies: Changes in clinical outcomes and management over time.Org: University of South Dakota Sanford School of Medicine (Sioux Falls, SD), Sioux Falls, SD, Sanford USD Medical Center, University of South Dakota Sanford School of Medicine, Sanford Health,
Abstract
Effects of concomitant gut-microbiome altering medications on immune checkpoint inhibitors therapy: A retrospective study.Org: University of Vermont Medical Center, Division of Hematology-Oncology, Department of Medicine, Seoul Medical Center, Seo-Gu, South Korea, University of Vermont Department of Medicine, University of Vermont Medical Center, Dept of Pharmacy, University of Vermont Biomedical Statistics,
Product
steroids + anti-TNF